Immunocore | 8-K: Current report
Immunocore | 8-K: Current report
Immunocore | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
Immunocore | 3: Initial statement of beneficial ownership of securities-Director KRISHANA RANJEEV
Immunocore | 3: Initial statement of beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
Immunocore | 8-K: Current report
Immunocore | 4: Statement of changes in beneficial ownership of securities-Director Kaul Siddharth
Immunocore | 4: Statement of changes in beneficial ownership of securities-Director Bell John Irving
Immunocore | 4: Statement of changes in beneficial ownership of securities-Director Herbst Roy Steven
Immunocore | 4: Statement of changes in beneficial ownership of securities-Director Peterson Kristine
Immunocore | 4: Statement of changes in beneficial ownership of securities-Director Ratcliffe Peter John
Immunocore | 8-K: Current report
Immunocore | 8-K: Immunocore reports first quarter financial results and provides a business update
Immunocore | 10-Q: Quarterly report
Immunocore | ARS: Annual Report to Security Holders
Immunocore | DEF 14A: Definitive information statements
Immunocore | 8-K: Current report
Immunocore | 424B7: Prospectus
Immunocore | 4: Statement of changes in beneficial ownership of securities-Officer St Leger Tina Amber
Immunocore | PRE 14A: Preliminary proxy statements relating to merger or acquisition
No Data